We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Greater Precision for Transformative Drug Discovery

Greater Precision for Transformative Drug Discovery content piece image

Target identification and characterization are key challenges in drug discovery and begin with identifying the function of a possible therapeutic target and its role in the disease. Limited Proteolysis Mass Spectrometry (LiP-MS) is a robust, reliable way to identify on- and off-target binding effects throughout the proteome, elucidate mechanisms of action and reveal potential toxicities.

Download this app note to discover how LiP-MS drug target deconvolution is:

  • Versatile
  • Unique
  • Insightful
  • Label-free
  • Efficient